Literature DB >> 19793957

Expression of glucose-dependent insulinotropic polypeptide in the zebrafish.

Michelle C Musson1, Lisa I Jepeal, Patrick D Mabray, Irina V Zhdanova, Wellington V Cardoso, M Michael Wolfe.   

Abstract

In mammals, glucose-dependent insulinotropic polypeptide (GIP) is synthesized predominately in the small intestine and functions in conjunction with insulin to promote nutrient deposition. However, little is known regarding GIP expression and function in early vertebrates like the zebrafish, a model organism representing an early stage in the evolutionary development of the compound vertebrate pancreas. Analysis of GIP and insulin (insa) expression in zebrafish larvae by RT-PCR demonstrated that although insa was detected as early as 24 h postfertilization (hpf), GIP expression was not demonstrated until 72 hpf, shortly after the completion of endocrine pancreatic development but prior to the commencement of independent feeding. Furthermore, whole mount in situ hybridization of zebrafish larvae showed expression of GIP and insa in the same tissues, and in adult zebrafish, RT-PCR and immunohistochemistry demonstrated GIP expression in both the intestine and the pancreas. Receptor activation studies showed that zebrafish GIP was capable of activating the rat GIP receptor. Although previous studies have identified four receptors with glucagon receptor-like sequences in the zebrafish, one of which possesses the capacity to bind GIP, a functional analysis of these receptors has not been performed. This study demonstrates interactions between the latter receptor and zebrafish GIP, identifying it as a potential in vivo target for the ligand. Finally, food deprivation studies in larvae demonstrated an increase in GIP and proglucagon II mRNA levels in response to fasting. In conclusion, the results of these studies suggest that although the zebrafish appears to be a model of an early stage of evolutionary development of GIP expression, the peptide may not possess incretin properties in this species.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19793957      PMCID: PMC2803629          DOI: 10.1152/ajpregu.00288.2009

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  33 in total

1.  Comparative study of family 2 GPCRs in Fugu rubripes.

Authors:  João Cardoso; Deborah Power; Melody Clark
Journal:  Ann N Y Acad Sci       Date:  2005-04       Impact factor: 5.691

2.  Proliferation and differentiation of intestinal epithelial cells during development of Barbus conchonius (Teleostei, Cyprinidae).

Authors:  J H Rombout; H W Stroband; J J Taverne-Thiele
Journal:  Cell Tissue Res       Date:  1984       Impact factor: 5.249

3.  Hatching in zebrafish (Danio rerio) embryos exposed to a 50 Hz magnetic field.

Authors:  K S Skauli; J B Reitan; B T Walther
Journal:  Bioelectromagnetics       Date:  2000-07       Impact factor: 2.010

4.  Early developmental expression of two insulins in zebrafish (Danio rerio).

Authors:  Madhusudhan R Papasani; Barrie D Robison; Ronald W Hardy; Rodney A Hill
Journal:  Physiol Genomics       Date:  2006-07-18       Impact factor: 3.107

5.  Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat.

Authors:  C C Tseng; T J Kieffer; L A Jarboe; T B Usdin; M M Wolfe
Journal:  J Clin Invest       Date:  1996-12-01       Impact factor: 14.808

6.  Dietary regulation of glucose-dependent insulinotropic peptide (GIP) gene expression in rat small intestine.

Authors:  Y Higashimoto; E C Opara; R A Liddle
Journal:  Comp Biochem Physiol C Pharmacol Toxicol Endocrinol       Date:  1995-02

7.  Isolation and structure-function studies of a glucagon-like peptide 1 receptor from goldfish Carassius auratus: identification of three charged residues in extracellular domains critical for receptor function.

Authors:  Chung-Man Yeung; Svetlana Mojsov; Pui-Yee Mok; Billy K C Chow
Journal:  Endocrinology       Date:  2002-12       Impact factor: 4.736

8.  Incretin and islet hormonal responses to fat and protein ingestion in healthy men.

Authors:  Richard D Carr; Marianne O Larsen; Maria Sörhede Winzell; Katarina Jelic; Ola Lindgren; Carolyn F Deacon; Bo Ahrén
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-08       Impact factor: 4.310

9.  Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man.

Authors:  S Cataland; S E Crockett; J C Brown; E L Mazzaferri
Journal:  J Clin Endocrinol Metab       Date:  1974-08       Impact factor: 5.958

10.  Evolution of secretin family GPCR members in the metazoa.

Authors:  João C R Cardoso; Vanda C Pinto; Florbela A Vieira; Melody S Clark; Deborah M Power
Journal:  BMC Evol Biol       Date:  2006-12-13       Impact factor: 3.260

View more
  4 in total

1.  Evolutionary conservation of glucose-dependent insulinotropic polypeptide (GIP) gene regulation and the enteroinsular axis.

Authors:  Michelle C Musson; Lisa I Jepeal; Torfay Sharifnia; M Michael Wolfe
Journal:  Regul Pept       Date:  2010-06-02

Review 2.  Glucose metabolism in fish: a review.

Authors:  Sergio Polakof; Stéphane Panserat; José L Soengas; Thomas W Moon
Journal:  J Comp Physiol B       Date:  2012-04-05       Impact factor: 2.200

3.  In vivo drug discovery for increasing incretin-expressing cells identifies DYRK inhibitors that reinforce the enteroendocrine system.

Authors:  Lianhe Chu; Michishige Terasaki; Charlotte L Mattsson; Romain Teinturier; Jérémie Charbord; Ercument Dirice; Ka-Cheuk Liu; Michael G Miskelly; Qiao Zhou; Nils Wierup; Rohit N Kulkarni; Olov Andersson
Journal:  Cell Chem Biol       Date:  2022-08-22       Impact factor: 9.039

4.  In vivo monitoring of intracellular Ca2+ dynamics in the pancreatic β-cells of zebrafish embryos.

Authors:  Reka Lorincz; Christopher H Emfinger; Andrea Walcher; Michael Giolai; Claudia Krautgasser; Maria S Remedi; Colin G Nichols; Dirk Meyer
Journal:  Islets       Date:  2018-12-06       Impact factor: 2.694

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.